UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000015160 |
|---|---|
| Receipt number | R000017553 |
| Scientific Title | Prevalence of Fabry disease in patients with cerevrovascular disease. |
| Date of disclosure of the study information | 2014/09/15 |
| Last modified on | 2016/03/15 12:23:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prevalence of Fabry disease in patients with cerevrovascular disease.
Acronym
Prevalence of Fabry disease in patients with cerevrovascular disease.
Scientific Title
Prevalence of Fabry disease in patients with cerevrovascular disease.
Scientific Title:Acronym
Prevalence of Fabry disease in patients with cerevrovascular disease.
Region
| Japan |
Condition
Condition
Cerevrovascular disease
Classification by specialty
| Medicine in general | Cardiology | Nephrology |
| Neurology |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
To know the preverlence of Fabry disease in reratively young patients with cerebrovascular disease.
Basic objectives2
Others
Basic objectives -Others
To know the preverlence of Fabry disease in reratively young patients with cerebrovascular disease.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
serum alfa-GAL activity, serum Lyso-Gb3, gene
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 15 | years-old | <= |
Age-upper limit
| 60 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
None
Key exclusion criteria
None
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Ken Johkura |
Organization
Yokohama Stroke and Brain Center
Division name
Neurology
Zip code
Address
1-2-1 Takigashira, Isogo-ku, Yokohama city, Knagawa, Japan
TEL
045-753-2500
ke00-johkura@city.yokohama.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Ryoko Imazeki |
Organization
Yokohama Stroke and Brain Center
Division name
Neurology
Zip code
Address
1-2-1 Takigashira, Isogo-ku, Yokohama city, Knagawa, Japan
TEL
045-753-2500
Homepage URL
Kisaragi1967@aol.com
Sponsor or person
Institute
Yokohama Stroke and Brain Ccenter
Institute
Department
Personal name
Funding Source
Organization
Yokohama Stroke and Brain Center
Organization
Division
Category of Funding Organization
Local Government
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 09 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 06 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 06 | Month | 09 | Day |
Last follow-up date
| 2016 | Year | 01 | Month | 15 | Day |
Date of closure to data entry
| 2016 | Year | 01 | Month | 15 | Day |
Date trial data considered complete
| 2016 | Year | 01 | Month | 15 | Day |
Date analysis concluded
| 2016 | Year | 04 | Month | 30 | Day |
Other
Other related information
serum alfa-GAL activity, serum Lyso-Gb3, gene
Management information
Registered date
| 2014 | Year | 09 | Month | 15 | Day |
Last modified on
| 2016 | Year | 03 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017553
